ANVS
Price
$4.71
Change
-$0.41 (-8.02%)
Updated
Dec 18, 04:59 PM (EDT)
111 days until earnings call
VTYX
Price
$2.31
Change
-$0.06 (-2.53%)
Updated
Dec 18, 04:35 PM (EDT)
92 days until earnings call
Ad is loading...

ANVS vs VTYX

Header iconANVS vs VTYX Comparison
Open Charts ANVS vs VTYXBanner chart's image
Annovis Bio
Price$4.71
Change-$0.41 (-8.02%)
Volume$914
CapitalizationN/A
Ventyx Biosciences
Price$2.31
Change-$0.06 (-2.53%)
Volume$1.4K
CapitalizationN/A
ANVS vs VTYX Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. VTYX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and VTYX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ANVS: $5.11 vs. VTYX: $2.37)
Brand notoriety: ANVS and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 100% vs. VTYX: 77%
Market capitalization -- ANVS: $70.5M vs. VTYX: $167.58M
ANVS [@Biotechnology] is valued at $70.5M. VTYX’s [@Biotechnology] market capitalization is $167.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 4 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 4 bullish, 5 bearish.
  • VTYX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than VTYX.

Price Growth

ANVS (@Biotechnology) experienced а -9.72% price change this week, while VTYX (@Biotechnology) price change was -14.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ANVS is expected to report earnings on Apr 08, 2025.

VTYX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($168M) has a higher market cap than ANVS($65M). VTYX YTD gains are higher at: -4.049 vs. ANVS (-72.674). ANVS has higher annual earnings (EBITDA): -30.4M vs. VTYX (-164.94M). VTYX has more cash in the bank: 275M vs. ANVS (12.6M). ANVS (0) and VTYX (0) have equivalent revenues.
ANVSVTYXANVS / VTYX
Capitalization65M168M39%
EBITDA-30.4M-164.94M18%
Gain YTD-72.674-4.0491,795%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.6M275M5%
Total DebtN/A11M-
TECHNICAL ANALYSIS
Technical Analysis
ANVSVTYX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX21.550.16
+0.75%
ProFunds Pharmaceuticals UltraSector Svc
GEQZX60.44N/A
N/A
GuideStone Funds Equity Index Investor
ABCVX23.81-0.07
-0.29%
American Beacon The London Co Inc Eq Inv
OTPSX36.21-0.16
-0.44%
ProFunds NASDAQ-100 Svc
GLESX13.44-0.08
-0.59%
GS Energy Infrastructure Fd R6 Shares

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with MDGL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+2.20%
MDGL - ANVS
36%
Loosely correlated
-1.58%
ADXN - ANVS
34%
Loosely correlated
-0.64%
EWTX - ANVS
33%
Poorly correlated
-7.71%
VTYX - ANVS
32%
Poorly correlated
+5.33%
AXON - ANVS
31%
Poorly correlated
-2.09%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with IOVA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+5.33%
IOVA - VTYX
41%
Loosely correlated
-0.38%
AKRO - VTYX
38%
Loosely correlated
+4.72%
RAPT - VTYX
38%
Loosely correlated
-4.56%
PYPD - VTYX
37%
Loosely correlated
+2.88%
DYN - VTYX
36%
Loosely correlated
+0.23%
More